Literature DB >> 17543001

Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most.

L Gellert1, B Jalaludin, M Levy.   

Abstract

BACKGROUND: Hepatocellular cancer (HCC) is a serious complication of cirrhosis and chronic hepatitis B infection. The aim of the study was to determine the characteristics of patients with HCC presenting within the South West Sydney area, including an analysis of the rates and benefits of hepatocellular surveillance.
METHODS: Data from patients with HCC presenting to Liverpool and Bankstown Hospitals from July 1993 to June 2003 were analysed retrospectively, predominantly from hospital records.
RESULTS: Of the 151 HCC patients, 41% were Asian born. Most of the patients required an interpreter. Chronic viral hepatitis infection was present in 91 patients, of whom only 7% had previously received antiviral therapy. Alcohol alone was considered responsible in 31 patients. Cirrhosis could be documented in 58% of patients. Most of the patients (75%) presented symptomatically. The median survival was 5.1 months. When HCC was detected by surveillance, the tumours were slightly but not significantly more likely to be operable and the patients tended to be offered some form of active treatment more frequently. Multivariate analysis identified detection by surveillance, lower Child-Pugh score, smaller tumour size and eligibility for some form of treatment to be associated with a more favourable outcome.
CONCLUSION: We observed low rates of surveillance for HCC, low recognition of cirrhosis before development of HCC and low rates of prior treatment of viral hepatitis. The poor outcome of HCC in the small group who had some sort of community surveillance is also a concern requiring further investigation.

Entities:  

Mesh:

Year:  2007        PMID: 17543001     DOI: 10.1111/j.1445-5994.2007.01392.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  5 in total

1.  Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation.

Authors:  Monica C Robotin; Melanie Q Kansil; Jacob George; Kirsten Howard; Steven Tipper; Miriam Levy; Nghi Phung; Andrew G Penman
Journal:  BMC Health Serv Res       Date:  2010-07-21       Impact factor: 2.655

2.  Listening to the consumer voice: developing multilingual cancer information resources for people affected by liver cancer.

Authors:  Monica C Robotin; Mamta Porwal; Max Hopwood; Debbie Nguyen; Minglo Sze; Carla Treloar; Jacob George
Journal:  Health Expect       Date:  2016-02-29       Impact factor: 3.377

3.  Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.

Authors:  Amit G Singal; Anjana Pillai; Jasmin Tiro
Journal:  PLoS Med       Date:  2014-04-01       Impact factor: 11.069

4.  Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.

Authors:  Chia-Yang Hsu; Yun-Hsuan Lee; Po-Hong Liu; Cheng-Yuan Hsia; Yi-Hsiang Huang; Han-Chieh Lin; Yi-You Chiou; Fa-Yauh Lee; Teh-Ia Huo
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

5.  Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia.

Authors:  Monica C Robotin; Ximena Masgoret; Mamta Porwal; David Goldsbury; Chee Khoo; Jacob George
Journal:  Clin Epidemiol       Date:  2017-12-21       Impact factor: 4.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.